v3.26.3
SEGMENTS INFORMATION - Reconciliation of Segment Operating EBITDA to Income from Continuing Operations Before Income Taxes (Details) - USD ($)
$ in Millions
 3 Months Ended 9 Months Ended
Sep. 30, 2026
Sep. 30, 2025
Sep. 30, 2026
Sep. 30, 2025
Segment Reporting [Line Items]        
Depreciation and amortization $ 155 $ 162 $ 464 $ 488
Interest income 27 17 61 52
Interest expense 40 84 121 250
Non-operating pension/OPEB benefit (costs) credits (2) 0 (3) 2
Foreign exchange gains (losses), net 6 (12) 20 (29)
Future Reimbursable Indirect Costs 0 25 8 75
Corporate DDOB Remediation Costs 4 3 14 8
Significant items charge (22) (76) (76) (157)
Income from continuing operations before income taxes 279 91 726 266
Healthcare & Water Technologies        
Segment Reporting [Line Items]        
Total segment operating EBITDA 263 246 765 717
Diversified Industrials        
Segment Reporting [Line Items]        
Total segment operating EBITDA 242 219 655 603
Operating Segments        
Segment Reporting [Line Items]        
Total segment operating EBITDA 505 465 1,420 1,320
Operating Segments | Healthcare & Water Technologies        
Segment Reporting [Line Items]        
Total segment operating EBITDA 263 246 765 717
Significant items charge 4 (7) (4) (5)
Operating Segments | Diversified Industrials        
Segment Reporting [Line Items]        
Total segment operating EBITDA 242 219 655 603
Significant items charge (11) (7) (31) (13)
Corporate        
Segment Reporting [Line Items]        
Total segment operating EBITDA (36) (29) (89) (101)
Significant items charge $ (15) $ (62) $ (41) $ (139)